Utrogestan® soft vaginal capsules
Indications:
Utrogestan® is indicated in women for:
– Luteal phase supplementation during the course of assisted reproductive technology (ART) cycles.
– Prevention of preterm birth in women with a singleton pregnancy who have a short cervix (second trimester ultrasound cervix ≤25mm) and/or a history of spontaneous preterm birth.
Access technical file Utrogestan® 200 mg soft vaginal capsules, 15 capsules Access technical file Utrogestan® 300 mg soft vaginal capsules, 15 capsulesUtrogestan® soft vaginal capsules
Indicated for luteal phase supplementation during ART cycles and prevention of preterm birth in women with a singleton pregnancy who have a short cervix and/or a history of spontaneous preterm birth.
Indicated for luteal phase supplementation during ART cycles.
Link to each of the data sheets.
Utrogestan® 200mg June 2022 :.:: CIMA ::. FICHA TECNICA UTROGESTAN 200 MG CAPSULAS VAGINALES BLANDAS (aemps.es)
Datasheet Utrogestan® 300mg March 2023: .:: CIMA ::. FICHA TECNICA UTROGESTAN 300 MG CAPSULAS VAGINALES BLANDAS (aemps.es)
Ownership: BESINS Healthcare
Marketed and distributed in Spain by Laboratorios Rubió as local representative.
Last update: July 2024
The information contained in this area is directed exclusively to healthcare professionals with the capacity to prescribe or dispense medications.